Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Raises $1.2M in Private Financing

NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen said in a regulatory document that it has raised more than $1.2 million toward a targeted $1.5 million private financing round. 

Through a spokesperson, the Gaithersburg, Md.-based firm declined to comment. OpGen said in a document filed with the US Securities and Exchange Commission that there were nine investors in the round, but did not identify them. It also did not say how the funds would be used. 

It said that the types of securities offered were debt; an option, warrant, or other right to acquire another security; and security to be acquired upon the exercise of an option, warrant, or other right to secure security. 

OpGen said last July that it raised $1.1 million of a targeted $1.5 million financing round.